Form D · Other

Receptor Life Sciences, Inc.

Seattle, WA · CIK 0001693768

Offering snapshot reported Oct 4, 2018 · SEC filing

Reported sold
$7.57M
Offering amount: $7.57M
Investors reported
55
Form D · investor count
Minimum accepted
$25K
Reported outside-investor minimum
First sale
Dec 23, 2016
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$3.79M$7.57MJan 6, 2017: $2,525,000.00Jan 6, 2017Oct 4, 2018: $7,574,970.00Oct 4, 2018

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$2,525,000 → $7,574,970
  • Reported investors21 → 55

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Oct 4, 2018Amendment$7,574,970$5,049,970vs Jan 6, 201755SEC filing
Jan 6, 2017Initial$2,525,000No comparison21SEC filing

Offering details

Securities
Debt, Security to be acquired
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-277870

Source: Form D, filed Oct 4, 2018. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Traci Carman Director, Executive
Arthur Rubinfeld Director
David Thomson Director
Gregory Wesner Director

Issuer details

Industry: Other (See others in industry)

Address:
C/O Lane Powell Pc 1420 5 Th Ave., Suite 4200
Seattle, WA, 98101